US Stock MarketDetailed Quotes
RPRX Royalty Pharma
- 26.010
- +0.210+0.81%
Close Nov 19 16:00 ET
- 26.030
- +0.020+0.08%
Post 18:35 ET
11.56BMarket Cap10.24P/E (TTM)
26.030High25.470Low7.30MVolume25.630Open25.800Pre Close189.00MTurnover1.88%Turnover Ratio10.28P/E (Static)444.30MShares30.92252wk High1.68P/B10.09BFloat Cap24.80152wk Low0.83Dividend TTM387.82MShs Float51.220Historical High3.19%Div YieldTTM2.17%Amplitude24.801Historical Low25.891Avg Price1Lot Size
Royalty Pharma Key Stats
EPS
According to the latest financial report of Royalty Pharma, the latest earnings per share (TTM) for the company is 1.21. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Royalty Pharma's free cash flow? The latest report shows it as 703.61M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Royalty Pharma shows that the company's current ratio is 1.54, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Royalty Pharma, the quick ratio is 1.53, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Royalty Pharma? The latest ROE figure is 8.15%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Royalty Pharma, the total asset return on investment (ROA) is 3.05%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Royalty Pharma's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Royalty Pharma, the net profit margin is 142.80%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data